Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
07/2003
07/03/2003US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines
07/03/2003US20030125523 Novel neuropilin/growth factor complexes and uses thereof
07/03/2003US20030125522 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
07/03/2003US20030125519 Ligand for the c-kit receptor and methods of use thereof
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030125242 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
07/03/2003US20030124718 Cytolytic T lymphocyte (CTL); viricides; particle acceleration apparatus
07/03/2003US20030124704 Neuroprotectants; inhibition of axonal growth; antitumor agents
07/03/2003US20030124678 Interleukin-2 mutants with reduced toxicity
07/03/2003US20030124629 Methods of detecting a cell
07/03/2003US20030124602 Tumour suppresor and uses thereof
07/03/2003US20030124582 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy
07/03/2003US20030124115 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity
07/03/2003US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof
07/03/2003CA2471373A1 Modified tridegins, their preparation and their use as transglutaminase inhibitors
07/03/2003CA2471136A1 Mono-and dual chemokine/cytokine constructs
07/03/2003CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration
07/03/2003CA2466885A1 Non-human primate fc receptors and methods of use
07/03/2003CA2465283A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
07/02/2003EP1323737A2 Il-3 variant hematopoiesis fusion protein
07/02/2003EP1322755A1 Human and mouse targeting peptides identified by phage display
07/02/2003EP1322747A2 Improved formulations using heat shock/stress protein-peptide complexes
07/02/2003CN1113068C Materials for production of nanometer structure and use thereof
07/01/2003US6586575 Purification of somatotropin from transformed microorganisms
07/01/2003US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization
07/01/2003CA2123303C Icams immunoglobulin constant region soluble fusion proteins
07/01/2003CA2122338C Novel human cdc25 genes, encoded products and uses therefor
06/2003
06/26/2003WO2003052091A1 Growth factor modified protein matrices for tissue engineering
06/26/2003WO2003052050A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/26/2003WO2003051923A2 Novel g-protein coupled receptors and dna sequences thereof
06/26/2003WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003US20030120059 Cell surface molecule-induced macrophage activation
06/26/2003US20030120045 Immobilization onto polyoxyethylene glycol
06/26/2003US20030119149 Fusion protein capable of forming a trimer; nonimmunogenic; modulates signaling of tumor necrosis family receptors
06/26/2003US20030119104 Genetic engineered artificial chromosomes in plants, animals
06/26/2003US20030119099 Genes containing a DNA sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof
06/26/2003US20030119070 Complexing ligand, peptide ; displacement of one ligand with another
06/26/2003US20030119013 Identification of essential genes of Aspergillus fumigatus and methods of use
06/26/2003US20030118611 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination
06/26/2003CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003CA2470419A1 Growth factor modified protein matrices for tissue engineering
06/26/2003CA2456210A1 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/25/2003EP1320604A2 Cripto mutant and uses thereof
06/25/2003EP1320585A2 Oxidoreductases
06/25/2003EP1320551A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma
06/25/2003EP1320549A2 Pumpcn compositions and uses thereof
06/25/2003EP1117693A4 Intein mediated peptide ligation
06/25/2003EP0753073B1 Heat-inducible n-degron module
06/25/2003CN1426473A Heterologous expression of neisserial proteins
06/25/2003CN1426471A Hybrid expression of neisserial proteins
06/25/2003CN1426306A Method and compositions for impairing multiplication of HIV-1
06/24/2003US6583272 Protein conjugate for use in the treatment of blood disorders
06/24/2003US6582915 Production of anti-self bodies from antibody segment repertories and displayed on phage
06/24/2003CA2012311C New protein-polycation-conjugate
06/19/2003WO2003050265A2 Compositions and methods for normalizing assays
06/19/2003WO2003050254A2 Novel chimeric tnf ligands
06/19/2003WO2003027252A3 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
06/19/2003WO2003016517A3 Kinase crystal structures
06/19/2003WO2002043660A3 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
06/19/2003WO2002042462A3 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
06/19/2003WO2002040631A3 Dipeptide seryl-histidine and related oligopeptides cleave dna, protein, and a carboxyl ester
06/19/2003WO2002004514A3 Compositions and methods for the therapy and diagnosis of lung cancer
06/19/2003US20030114659 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
06/19/2003US20030114398 Monoclonal antiidiotype antibody 1A7 eliciting an anti-ganglioside GD2 response and overcomes immune tolerance; detecting an anti-GD2 antibody bound to a tumor cell; kits; melanoma, neuroblastoma, glioma, soft tissue sarcoma
06/19/2003US20030114368 Immunotoxins directed against malignant cells
06/19/2003US20030113919 Anticancer agents
06/19/2003US20030113871 Glycoprotein hormones; human chorionic gonadotropin; carboxy terminal peptides (ctp); increaseing half life of polypeptides; antipernicious anemia drugs
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113868 Human metabotropic glutamate receptor subtype mGluR7b
06/19/2003US20030113749 Interaction trap systems for detecting protein interactions
06/19/2003US20030113747 Genetically engineered adenosine triphosphate generating polypeptide; sequences determination; reporter molecules
06/19/2003US20030113337 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
06/19/2003US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies
06/19/2003CA2472054A1 Compositions and methods for normalizing assays
06/19/2003CA2469494A1 Novel chimeric tnf ligands
06/18/2003EP1319712A2 Fusion protein having enhanced in vivo activity of erythropoietin
06/18/2003EP1319072A2 G-protein coupled receptor hfrbn63
06/18/2003EP1319069A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1318827A1 Polymer-modified synthetic proteins
06/18/2003CN1425072A Gene therapy of HIV-positive patients by the expression of membrane-anchored gp41 peptides
06/18/2003CN1425066A Novel stra6 polypeptides
06/18/2003CN1111429C Urease-based vaccine against HeIicobacter infection
06/17/2003US6579973 Compositions for the treatment and diagnosis of breast cancer and methods for their use
06/12/2003WO2003048390A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003WO2003048345A1 Phenotypic screen of chimeric proteins
06/12/2003WO2003048334A2 Immunocytokines with modulated selectivity
06/12/2003WO2003048210A1 Fusion protein having enhanced in vivo erythropoietin activity
06/12/2003WO2002012345A3 Soluble zcytor 11 cytokine receptors
06/12/2003US20030110529 Genetic engineering gene expression cassette; adjustment protein cell cycles; plants
06/12/2003US20030110528 Novel ecdysone receptors and methods for their use
06/12/2003US20030109678 Methods and means for regulation of gene expression
06/12/2003US20030109437 Peptides and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such
06/12/2003US20030109436 Wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. DNA sequence codes for cells
06/12/2003US20030109000 Culture product; binding polypeptides containing activated end groups
06/12/2003US20030108966 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/12/2003US20030108965 Using polypeptide, detection of antibody; cancer of ovaries
06/12/2003US20030108932 Ras guanine-nucleotide-exchange factor 1 (nrg1)
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003CA2811997A1 Antibodies against monocyte chemotactic proteins
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 295